Connection

Miguel Abboud to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Miguel Abboud has written about Drug Resistance, Neoplasm.
Miguel Abboud
Connection Strength
0.203
Drug Resistance, Neoplasm
  1. NUDT15 and TPMT genetic polymorphisms are related to 6-mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon. Pediatr Blood Cancer. 2017 01; 64(1):146-150.
    View in: PubMed
    Score: 0.115
  2. Delayed initiation of front-line imatinib therapy predicts for poor response to nilotinib as second-line treatment of imatinib-resistant or intolerant CML: single center report of the ENACT trial in Lebanon. Int J Hematol. 2012 Oct; 96(4):521-4.
    View in: PubMed
    Score: 0.087
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.